article thumbnail

Report: ANDA Litigation is Declining

IP Watchdog

Last week, Patexia released its second annual ANDA Litigation Intelligence Report in which we covered the rankings, statistics and comprehensive analysis of abbreviated new drug application (ANDA) and Hatch-Waxman stakeholders.

Reporting 124
article thumbnail

DECEMBER 2022 RETAIL PATENT LITIGATION REPORT

LexBlog IP

As usual, I prepared the report in partnership with and using Docket Navigator and its powerful database. Finally, please let me know if you have thoughts about the report or changes you would like to see. I am preparing it as a service for retailers and their supply chain who may want an overview of the patent litigation landscape.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

IP litigation oral report

Olartemoure Blog

On 09 February 2023, the (Andean Court of Justice) ACCJ issued Rule 01/2023, which set procedural costs to attend requests for oral reports within the PI stage at USD 2,500. La entrada IP litigation oral report se publicó primero en OlarteMoure | Intellectual Property.

article thumbnail

AUGUST 2022 RETAIL PATENT LITIGATION REPORT

LexBlog IP

As usual, I prepared the report in partnership with and using Docket Navigator and its powerful database. Finally, please let me know if you have thoughts about the report or changes you would like to see. I am preparing it as a service for retailers and their supply chain who may want an overview of the patent litigation landscape.

article thumbnail

JULY 2022 RETAIL PATENT LITIGATION REPORT

LexBlog IP

As usual, I prepared the report in partnership with and using Docket Navigator and its powerful database. Finally, please let me know if you have thoughts about the report or changes you would like to see. I am preparing it as a service for retailers and their supply chain who may want an overview of the patent litigation landscape.

article thumbnail

AIPPI Congress (Report 2): Ethics in Funding IP Litigation

The IPKat

One panel session she was unable to get to was on the Ethics in Funding IP Litigation moderated by Gustavo de Freitas Morais ( Managing Partner at Dannemann Siemsen ). Over to Emily : "The panel started by introducing the different structures for financing litigation. The panel examined the funding business model.

article thumbnail

Moderna Litigation Against BioNTech and Pfizer Stayed Pending IPR

JD Supra Law

We previously reported on the litigation brought by ModernaTX, Inc. and Moderna US, Inc. collectively, “Moderna”) against BioNTech SE, BioNTech Manufacturing GmbH, BioNTech US Inc. collectively, “BioNTech”), and Pfizer Inc.